Navigation Links
Joint Commission International Achieves Accreditation from ISQua

OAK BROOK, Ill., Jan. 3 /PRNewswire-USNewswire/ -- Joint Commission International (JCI) today announced its accreditation by the International Society for Quality in Health Care. JCI is a division of Joint Commission Resources, Inc. (JCR), a private, not-for-profit affiliate of The Joint Commission.

JCI is a global leader in health care accreditation and since 1999 has accredited more than 140 hospitals in 27 countries. This external endorsement by ISQua is a milestone achievement that demonstrates the quality of JCI's accreditation services.

ISQua, a non-profit, independent organization with members in more than 70 countries, is known as the accreditor of accrediting bodies. Accreditation by ISQua provides assurance that the standards, training and processes used by JCI to survey the performance of health care organizations meet the highest international benchmarks for accreditation entities.

"I'm proud to announce JCI's accreditation by ISQua. It demonstrates the dedication and commitment of our Board, staff and surveyors to improving health care quality and safety through the process of accreditation and it allows us to provide external validation of this commitment to our clients," says Karen H. Timmons, CEO, Joint Commission International.

Joint Commission International chose to pursue ISQua accreditation because:

-- It provides confidence and credibility through formal worldwide recognition that an organization meets international standards specifically developed and tested for health care external evaluation bodies, and

-- It involves an impartial and independent review system.

Accreditation by ISQua was a two-part process that touched upon every aspect of how JCI operates. The first part of the process, completed in 2005, involved applying for accreditation, an evaluation of JCI's accreditation standards based on a set of principles created by ISQua, and a self-evaluation by JCI of its compliance with ISQua's standards. The self-evaluation process included everything from the JCI accreditation application process to the deployment of surveyors to JCI's human resources practices, finances and quality improvement processes. JCI spent a year preparing the detailed self-evaluation report and other documents required for submission prior to the arrival of the survey team. The second phase concluded in July with the on-site survey.

For more information about JCI, please visit or call 1.630.268.7400.

Joint Commission International (JCI) was established in 1997 as a division of Joint Commission Resources, Inc. (JCR), a private, not-for-profit affiliate of The Joint Commission. Through international accreditation, consultation, publications and education programs, JCI extends The Joint Commission's mission worldwide by helping to improve the quality of patient care by assisting international health care organizations, public health agencies, health ministries and others evaluate, improve and demonstrate the quality of patient care and enhance patient safety in more than 60 countries.

SOURCE Joint Commission International
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
2. Joint NJ/NY Rally for Addiction Recovery to Be Hub of Events Nationwide
3. Joint Juice Launches New Ready-to-Drink Glucosamine & Vitamin-Enhanced Dietary Supplement Water Nationwide
4. SAIC Selected to Support the U.S. Military Theater Medical Information Program-Joint
5. The impact of physical activity on weight-bearing knee joint
6. Joint Center Says New Approach Required to Reduce Black Infant Mortality
7. Merlyn Medical Announces FDA Approval for FlexWarmer in a Joint Agreement with Elltec and Suzuken
8. The Joint Commission Enhances Quality Check Website
9. OCS and Press Ganey Partner to Create Joint Analysis of Outcomes and Satisfaction
10. More Damage Than Good? Shock Survey Reveals Sport can Actually be bad for Your Joints
11. Delaware Court Approves Bioenvision, Genzyme Joint Petition
Post Your Comments:
(Date:11/29/2015)... ... 29, 2015 , ... Effective immediately, every single IguanaMed scrub style will be ... Target is offering a “Buy One Scrub Set, Get the 2nd Scrub Set 50% ... IguanaMed at a discounted price. , IguanaMed’s mission is to outfit every ...
(Date:11/28/2015)... ... November 28, 2015 , ... Safe storage for contraceptive devices may not ... from Lakewood, New Jersey and the other from Bradley Beach, New Jersey, there is ... the expense of having to replace NuvaRings more often than necessary. As such, it ...
(Date:11/28/2015)... CA (PRWEB) , ... November 28, 2015 , ... Pixel ... fully customizable media panels to choose from, the possibilities are endless. Users have full ... more. With the ProPanel: Pulse masking effects, users are sure to get heads to ...
(Date:11/27/2015)... Angeles, CA (PRWEB) , ... November 27, 2015 , ... ... study carried out by the University of Toronto and the University of British Columbia ... of hospitalizations for head injuries. The article explains that part of the reason for ...
(Date:11/27/2015)... ... ... A team of Swiss doctors has released a report on mesothelioma relapse ... the findings on the website. Click here to read the details now. ... who were treated with chemotherapy followed by EPP surgery. Among the 106 patients who ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... 25, 2015  The American Academy of Pediatrics ... and the March of Dimes cheered today,s signature ... Infants Act of 2015 (S.799), which takes ... born exposed to drugs, such as opioids, and ... all three organizations have worked together leading advocacy ...
(Date:11/25/2015)... 25, 2015 On Tuesday, November 24, ... trial against Wright Medical Technology, Inc. for product ... metal-on-metal hip implant device, awarded $11 million in ... week trial and three days of deliberations, the ... was defectively designed and unreasonably dangerous, and that ...
(Date:11/25/2015)... TEL AVIV, Israel , November 25, 2015 /PRNewswire/ ... Ltd. (NASDAQ: KTOV ) (TASE: KTOV), a biopharmaceutical ... the simultaneous treatment of various clinical conditions, today announced ... of 3,158,900 American Depository Shares ( ADSs ), each ... to purchase up to 3,158,900 ADSs. The ADSs and ...
Breaking Medicine Technology: